FN1 and cancer: By preventing fibronectin binding to integrins, specific inhibitors or antibodies may disrupt such cell-cell interactions and impair homing of circulating cancer cells to specific sites of NETs accumulation thus reducing NETs-dependent metastatic dissemination.